Safety of subcutaneous immunotherapy with tyrosine-adsorbed house dust mite extracts in patients with allergic disease. Rev Alerg Mex [Internet]. 2017 Feb. 9 [cited 2026 Sep. 23];64(1):52-65. Available from: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/233